Polypharmacy is a growing problem and mechanisms of injury likely include potentially
inappropriate medications, total drug burden, known pairwise drug interactions, higher level …

Background The majority of patients with opioid use disorder do not receive medications for
opioid use disorder (MOUD), especially in rural areas. The patient-centered access to …

This paper is the forty-second consecutive installment of the annual anthological review of
research concerning the endogenous opioid system, summarizing articles published during …

Although opioid agonist therapy (OAT) is associated with positive health outcomes,
including improved HIV management, long-term retention in OAT remains low among …

Background Medication for opioid use disorder, including buprenorphine and methadone, is
considered the gold standard treatment for opioid use disorder (OUD). As the number of …

Background Medicaid recipients have a high burden of opioid overdose and opioid use
disorder (OUD). Opioid agonist therapies are an effective treatment for OUD, but there is a …

Introduction Infrequent use of and poor retention on evidence-based medications for alcohol
use disorder (MAUD) represent a treatment gap, particularly among people living with HIV …

Background After non-fatal opioid overdoses, opioid prescribing patterns are often
unchanged and the use of medications for opioid use disorder (MOUDs) remains low …

BACKGROUND Hospitalized patients with opioid use disorder (OUD) are rarely started on
buprenorphine or methadone maintenance despite evidence that these medications reduce …

Background: People living with HIV and opioid use disorder (OUD) are disproportionally
affected by adverse socio-structural exposures negatively affecting health, which have …